Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Decapeptyl for the treatment of advanced metastatic prostate cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde for second-line metastatic pancreatic cancer; Dysport for motor muscular disorders and medical aesthetics; NutropinAq for growth failure in children due to growth hormone (GH) deficiency, turner syndrome, chronic renal failure, and GH deficiency in adults; and Increlex for growth failure in children and adolescents. The company also offers Smecta for chronic and acute diarrhea, and pain associated with functional bowel diseases; Forlax for constipation; Fortrans/Eziclen for bowel cleansing prior to endoscopy, X-ray examination, and colonic surgery; and Tanakan for cognitive disorders in adults, vertigo of vestibular origin and vestibular rehabilitation, and tinnitus. In addition, it provides Xermelo for the carcinoid syndrome; Cometriq for medullary thyroid cancer; Smebiocta/SmectaFlora Protect, a food supplement; SmectaGas, a medical device used in the symptomatic treatment of gas-related gastrointestinal disorders and relief of gas-related symptoms; and Etiasa for inflammatory bowel diseases. Further, the company offers other consumer healthcare products in the gastro-intestinal area, including Buscopan, Clin4000, Prontalgine, Suppositoria Glycerini, Mucothiol, Floractin, and Mucodyne. Ipsen S.A. has agreements with Debiopharm; Exelixis; Galderma; Blueprint Medicines; TerSera Therapeutics; Rhythm Pharmaceuticals; Teijin; Braintree Laboratories; Ethypharm; Schwabe; BAKX Therapeutics Inc.; and Exicure. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France.
Ipsen Dividend Announcement
• Ipsen announced a annually dividend of $0.35 per ordinary share which will be made payable on 2024-06-14. Ex dividend date: 2024-05-31
• Ipsen annual dividend for 2024 was $0.35
• Ipsen annual dividend for 2023 was $0.35
• Ipsen's trailing twelve-month (TTM) dividend yield is 1.23%
• Ipsen's payout ratio for the trailing twelve months (TTM) is 22.75%
• Ipsen's dividend growth over the last five years (2018-2023) was 3.39% year
• Ipsen's dividend growth over the last ten years (2013-2023) was -0.07% year
Ipsen Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-05-31 | $0.35 | annually | 2024-06-14 |
2023-06-02 | $0.35 | annually | 2023-06-21 |
2022-05-31 | $0.32 | annually | 2022-06-09 |
2021-05-28 | $0.37 | annually | 2021-06-09 |
2020-06-03 | $0.28 | annually | 2020-06-12 |
2019-05-31 | $0.28 | annually | 2019-06-20 |
2018-06-04 | $0.29 | annually | 2018-06-21 |
2017-06-08 | $0.24 | annually | 2017-07-11 |
2016-05-31 | $0.24 | annually | 2016-07-13 |
2015-05-26 | $0.24 | annually | 2015-07-06 |
2014-06-04 | $0.37 | annually | 2014-07-02 |
2013-06-11 | $0.35 | annually |
Ipsen Dividend per year
Ipsen Dividend growth
Ipsen Dividend Yield
Ipsen current trailing twelve-month (TTM) dividend yield is 1.23%. Interested in purchasing Ipsen stock? Use our calculator to estimate your expected dividend yield:
Ipsen Financial Ratios
Ipsen Dividend FAQ
Other factors to consider when evaluating Ipsen as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Ipsen stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Ipsen's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Ipsen publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Ipsen distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Ipsen are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Ipsen sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Ipsen distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Ipsen declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Ipsen's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Ipsen's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.